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Abstract We have studied the incorporation of [14C]serine and
of [3H]sphingosine into sphingomyelin in the presence or absence
of brefeldin A (BFA) in three different cell types. Administration
of BFA (1 Wg/ml) to fibroblasts for 24 h increased the
incorporation of label into sphingomyelin 1.5^3 fold compared
with untreated controls. In contrast, BFA strongly decreased
sphingomyelin biosynthesis (4^5 fold) in cerebellar neurons as
well as in neuroblastoma cells. The effect of BFA on glyco-
sphingolipid formation, however, was similar in all three cell
types studied: an increased labeling of the precursor glycolipids
GlcCer, LacCer, GM3 and GD3 was paralleled by a decreased
formation of complex gangliosides, GM1, GD1a, GT1b and
GQ1b. Our data therefore suggest that in neuronal cells
sphingomyelin synthesis, like the formation of complex ganglio-
sides, is localized primarily distal to the BFA block, in a post-
Golgi compartment, most probably the trans-Golgi network,
whereas in fibroblasts sphingomyelin biosynthesis is mainly
localized prior to the BFA block, in the Golgi apparatus, as
has been shown for LacCer, GlcCer, GM3 and GD3 syn-
thases. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Sphingomyelin (SM) constitutes almost 10% of the cellular
lipids in mammalian cells and is preferentially concentrated in
the outer lea£et of the plasma membrane. Originally it was
considered to be mainly a structural element of the plasma
membrane, providing a rigid barrier to the environment. Since
the discovery of the ‘sphingomyelin cycle’ as a ubiquitous,
evolutionarily conserved signaling system analogous to well
known second messenger systems such as the cAMP and
phosphoinositide pathways, SM has emerged to the focus of
interest in many research laboratories [1,2].
SM, a phosphosphingolipid, is synthesized by the transfer
of phosphocholine (the water soluble phospholipid speci¢c
head group) from phosphatidylcholine onto ceramide (the hy-
drophobic sphingolipid speci¢c backbone) [3]. This reaction is
catalyzed by SM synthase. Since this enzyme is also able to
catalyze the reverse reaction, namely the formation of phos-
phatidylcholine from SM and diacylglycerol (DAG) [4], it
may regulate, in opposite directions, the concentration of
two lipid signaling molecules. The roles of DAG and ceramide
as anti-apoptotic and pro-apoptotic stimuli, respectively, sug-
gest the biological potential of SM synthase.
Large e¡orts have been made to determine the intracellular
localization of SM synthase. Subcellular fractionation studies
of rat liver have assigned the bulk of SM synthase activity to
the lumen of the cis-and medial-Golgi cisternae, while a minor
part, less than 10%, has been localized to the cell surface [5,6].
Subcellular fractionation studies with BHK cells, however,
provide evidence that the major site of synthesis of SM is
not the Golgi complex but the endocytic recycling pathway
[7]. This evidence has been extended in recent years and the
new data locate SM synthesis to the trans-Golgi network
(TGN) of these cells [8]. Contradictory results concerning
the localization of SM synthase were also obtained in studies
with brefeldin A (BFA), a macrocyclic lactone known to cause
Golgi disassembly and its redistribution to the endoplasmic
reticulum (ER), thus blocking the vesicular transport from the
Golgi complex to the plasma membrane [9]. Based on this
property BFA has often been used to map subcellular loca-
tions of di¡erent glycosyltransferases involved in glycosphin-
golipid biosynthesis [10^13].
BFA stimulated biosynthetic labeling of SM in CHO cells
[14] as well as in rat hepatocytes [15] con¢rming the Golgi
compartment as the major site of SM synthesis. In contrast,
BFA induced a considerable decrease of SM labeling with
radioactive precursors in cerebellar neurons, favoring a non-
Golgi location for SM synthesis [10]. To clarify if these dis-
crepancies are the result of di¡erent methodological ap-
proaches or rather due to a di¡erent subcellular location of
SM synthesis in various cell types, in the present study we
compared the e¡ect of BFA on sphingomyelin and on glyco-
sphingolipid biosynthesis in postmitotic primary cultured neu-
rons, neuroblastoma cells and ¢broblasts. Whereas our data
con¢rm the Golgi compartment as the main place for SM
synthesis in ¢broblasts, the formation of SM in neurons as
well as in neuroblastoma cells is likely to be associated with
more downstream elements of the secretory pathway, like the
TGN or the plasma membrane.
2. Materials and methods
2.1. Materials
Six day old NMRI mice were obtained from Dr. Brigitte Schmitz
from the Institut fu«r Anatomie und Physiologie der Haustiere of the
University of Bonn, Germany.
L-[3-14C]Serine (54 mCi/mmol) was purchased from Amersham-
Buchler (Braunschweig, Germany). [3-3H]Sphingosine (1700 Ci/mol)
was obtained according to Sarmientos et al. [16]. Culture media (Dul-
becco’s modi¢ed Eagle’s medium (DMEM) and minimal essential
medium (MEM) containing Glutamax0) were obtained from Life
Technologies, Inc. (Karlsruhe, Germany). DNase was from Roche
(Mannheim, Germany). Fetal calf serum (FCS), horse serum and
trypsin were supplied from Cytogen (Berlin, Germany). The plastic
culture dishes were from Falcon (Heidelberg, Germany). LiChroprep0
RP-18 and thin layer silica gel 60 plates were purchased from Merck
(Darmstadt, Germany). All other chemicals were of analytical grade
and obtained from Sigma (Deisenhofen, Germany) or Merck.
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2.2. Cell culture
Granule cells were cultured from cerebella of 6 day old mice ac-
cording to the method of Trenkner and Sidman [17]. Cells were iso-
lated by mild trypsinization (0.05%, w/v) and dissociated by repeated
passage through a constricted Pasteur pipette in a DNase solution
(0.1%, w/v). The cells were then suspended in DMEM containing
10% heat inactivated horse serum and plated onto poly-L-lysine
coated 8 cm2 Petri dishes (6U106 cells/dish). Twenty-four hours after
plating, cytosine arabinoside (AraC) was added to the medium
(4U1035 M) to arrest the division of non-neuronal cells [18]. After
4^5 days in culture, cells were used for metabolic studies.
Human ¢broblasts were from the Johanniter Children’s hospital,
Sankt Augustin, Germany. Cells were cultivated in DMEM supple-
mented with 10% heat inactivated FCS.
Human neuroblastoma cells (SHSY5Y) were kindly provided by
Dr. H. Ro«sner (Stuttgart, Germany) and were grown to con£uence
as described [19].
For experiments both ¢broblasts and neuroblastoma cells were
seeded into 8 cm2 Petri dishes and grown to con£uence.
2.3. Sphingolipid labeling, extraction and analysis
From the cells cultured in 8 cm2 plastic culture dishes medium was
removed and the cells were rinsed two times with MEM. The cells
were preincubated for 1 h in the absence or presence of BFA (1 Wg/ml)
in MEM containing 0.3% horse serum and 1% AraC (cerebellar neu-
rons) or 0.3% FCS (neuroblastoma cells and ¢broblasts). Metabolic
labeling of sphingolipids (SLs) was performed as described previously
[10] by addition of [14C]serine (1 WCi/ml) or [3H]sphingosine (2 WCi/ml)
to the culture medium (in which BFA was present or not, as men-
tioned above). After 24 h, when SL metabolism reached steady state
in all three cell types used, cells were washed three times with phos-
phate bu¡ered saline, harvested and centrifuged at 6000 rpm for 10
min. Total lipids were extracted from cell pellets with 6 ml of chloro-
form/methanol/water/pyridine (10:5:1:0.1, v/v) for 24 h at 50‡C.
Phospholipids were degraded by mild alkaline hydrolysis with meth-
anolic NaOH (100 mM) for 2 h at 37‡C. The lipid extracts were
desalted by reversed phase chromatography on LiChroprep RP18,
applied to TLC plates, and chromatographed with chloroform/meth-
anol/0.22% aqueous CaCl2 (60:35:8, v/v); SLs were visualized by
autoradiography and identi¢ed by their RF values and enzymatic
digestion [10]. Radioactive bands were evaluated by the bio-imaging
analyzer Fujix Bas 1000 using software TINA 2.09 (Raytest, Strau-
benhardt, Germany).
2.4. Protein determination
Cell protein was quanti¢ed as described by Bradford [20] using
bovine serum albumin as a standard. Before lipid extraction, cell
pellets were homogenized in 400 Wl of water and aliquots were used
for protein determination.
3. Results and discussion
It is well documented that BFA impairs the assembly of
ADP ribosylation factor (ARF) and coatomer on Golgi mem-
branes by inhibiting loading of ARF with GTP, thus a¡ecting
the budding and formation of transport vesicles and conse-
quently stopping anterograde vesicular transport between
Golgi compartments. This causes a redistribution of the Golgi
into the ER, and a block from these compartments to the
TGN, which is fused with early endosomes [21].
Based on this property BFA uncouples ganglioside biosyn-
thesis beyond GM3, GD3 and GT3 in murine cerebellar neu-
rons [10], CHO cells [11] and chick embryo neural retina cells
[13], respectively. We have now followed de novo formation
of SM in three di¡erent cell types by biosynthetic labeling of
cellular SLs with [14C]serine for 24 h in the presence or ab-
sence of 1 Wg/ml BFA (Fig. 1). To discriminate between the
e¡ect of BFA on SM formation via the de novo and salvage
pathways, in parallel experiments we used [3H]sphingosine
instead of [14C]serine as a labeled precursor for SL biosynthe-
sis (Fig. 2). Note that although sphingosine is not an inter-
Fig. 1. The e¡ect of BFA on [14C]serine incorporation into sphingo-
lipids of various cell types. Fibroblasts (lanes 1 and 2), neuroblasto-
ma cells SHSY5Y (lanes 3 and 4), and cerebellar neurons (lanes
5 and 6) were incubated for 1 h in the absence (lanes 1, 3 and 5) or
presence of 1Wg/ml BFA (lanes 2, 4 and 6). Then [14C]serine was
added to the culture medium. Cells were harvested after 24 h.
Sphingolipids were extracted, isolated, separated by TLC and de-
tected as described in Section 2. The mobilities of authentic sphin-
golipids are indicated. The terminology for gangliosides (GQ1b,
GT1b, GD1b, GD1a, GD3, GM1, GM3) is according to Svenner-
holm [26]. Other abbreviations are as follows: SM, sphingomyelin;
GlcCer, glucosylceramide; LacCer, lactosylceramide; Cer, ceramide.
*The nature of this band in ¢broblasts and neuroblastoma cells is
not known (it is not a ganglioside).
Table 1
The e¡ect of BFA on de novo sphingolipid biosynthesis in various cell types
Cell type [14C]Serine incorporated (% of control)
Cer GlcCer LacCer SM GM3 GD1a
Fibroblasts 415 458 166 267 612 nd
Neuroblastoma cells 441 521 nd 20 1714 nd
Cerebellar neurons 290 390 311 28 1490 30
Cells were preincubated in the absence (control) or presence of BFA (1 Wg/ml) for 1 h. [14C]Serine (1 WCi/ml) was then added and the cells
were incubated for 24 h. Lipids were extracted, puri¢ed and chromatographed as described in Section 2. The data presented were taken from
one representative experiment. Two additional experiments were performed and the data obtained were within a range of þ 10% of the data
given here. The total amount of radioactivity associated with cellular lipids is only slightly changed in the presence of BFA in all three cell
types.
nd, not determined since not detectable in controls or both controls and treated cells.
For abbreviations of sphingolipids see legend to Fig. 1.
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mediate in SL biosynthesis but exclusively a catabolic product
of ceramide [22], it can be reused for ceramide biosynthesis in
a salvage pathway [23].
As shown in Figs. 1 and 2 the SL pro¢le is cell type speci¢c.
Whereas in postmitotic, fully di¡erentiated neurons complex
gangliosides like GD1a and GT1b are clearly labeled, the SL
pattern of neuroblastoma cells resembles that of ¢broblasts,
complex gangliosides being poorly if at all labeled.
It is clear from Figs. 1 and 2 that BFA induces similar
changes in radioactive labeling of all SL species in the three
cell types investigated, except for SM. Thus, as shown before
in primary cultured neurons [10] and in CHO cells [11], BFA
causes a considerable accumulation of label in biosynthetically
‘early’ SL species, like ceramide, GlcCer, LacCer, GM3 and
GD3, with a simultaneous reduction of label incorporation
into more complex gangliosides that appear late in the bio-
synthetic pathway. Only the changes in biosynthetic labeling
of SM induced by BFA are cell type speci¢c. In primary
cultured neurons as well as in neuroblastoma cells incorpora-
tion of label into SM strikingly decreased (down to about 20%
of controls), independently of the radioactive precursor used
(Tables 1 and 2). In contrast, in ¢broblasts an almost three-
fold and nearly twofold increase of radioactively labeled SM
was found when [14C]serine or [3H]sphingosine were used,
respectively (Tables 1 and 2).
Thus, BFA increases incorporation of labeled precursors
into SM only in ¢broblasts, con¢rming earlier ¢ndings in
CHO cells [14] and in hepatocytes [15], whereas it causes a
striking decrease of SM synthesis in neurons and in neuro-
blastoma cells. It should be noticed that stimulation of SM
biosynthesis observed after administration of BFA is depen-
dent on the radioactive precursor used, being nearly two times
higher when [14C]serine is used instead of [3H]sphingosine.
Similar observations were made by Bru«ning et al. [14] in
CHO cells. After the addition of BFA the amount of
[3H]SM was increased twofold or ¢vefold when [3H]choline
or [3H]C8C8-Cer, respectively, were used to follow SM for-
mation.
Ceramide, the direct biosynthetic precursor of SM, is syn-
thesized on the cytosolic face of ER membranes [24]. In the
presence of BFA it is trapped in the newly formed ER/Golgi
compartment where it is accessible only for ER/Golgi resident
enzymes. Under these conditions only in ¢broblasts SM syn-
thase continues to convert ceramide to SM, indicating that
this enzyme, like glucosyltransferase and galactosyltransferase
I which are responsible for GlcCer and LacCer formation,
respectively, as well as the sialyltransferases that synthesize
GM3 and GD3, is located in the Golgi compartment [10,11].
Our observation that BFA decreases SM biosynthesis in
neurons as well as in neuroblastoma cells indicates that in
these cells SM biosynthesis like that of complex gangliosides
must be mainly located in a compartment that remains func-
tionally distinct from the ER. This compartment might be the
TGN as recently reported for BHK cells [8]. In addition,
subfractionation studies of cultured cerebellar neurons located
the sialyltransferases responsible for the formation of complex
gangliosides to the TGN [25].
The BFA induced block in SM biosynthesis was dramatic
(about 80%) but not absolute. The lack of complete inhibition
is, however, not surprising and may re£ect the dynamic nature
of the Golgi/TGN relation. Evidence for a vectorial rather
than a clearcut compartmentalization within the Golgi/TGN
compartment has already been provided for glycosyltransfer-
ases [25]. This may be true also for SM synthase. While the
majority of this enzyme may reside trans to the BFA block, in
a post-Golgi compartment, 10^20% may be located to Golgi
elements.
Fig. 2. The e¡ect of BFA on [3H]sphingosine incorporation into
sphingolipids of various cell types. Cerebellar neurons (lanes 1 and
2), ¢broblasts (lanes 3 and 4) and neuroblastoma cells SHSY5Y
(lanes 5 and 6) were incubated for 1 h in the absence (lanes 1, 3 and
5) or presence of 1 Wg/ml BFA (lanes 2, 4 and 6). Then
[3H]sphingosine was added to the culture medium. Cells were har-
vested after 24 h. Sphingolipids were extracted, isolated, separated
by TLC and detected as described in Section 2. The mobilities of
authentic sphingolipids are indicated. For abbreviations see legend
to Fig. 1.
Table 2
The e¡ect of BFA on sphingolipid biosynthesis in various cell types
Cell type [3H]Sphingosine incorporated (% of control)
Cer GlcCer LacCer SM GM3 GM1 GD1a
Cerebellar neurons 162 307 182 25 304 25 20
Fibroblasts 111 185 nd 170 250 nd nd
Neuroblastoma cells 105 290 182 20 307 nd nd
Cells were preincubated in the absence (control) or presence of BFA (1 Wg/ml) for 1 h. [3H]Sphingosine (1 WCi/ml) was then added and the cells
were incubated for 24 h. Lipids were extracted, puri¢ed and chromatographed as described in Section 2. The data presented were taken from
one representative experiment. Two additional experiments were performed and the data obtained were within a range of þ 10 of the data
given here.
nd, not determined since not detectable in controls or both controls and treated cells.
For abbreviations of sphingolipids see legend to Fig. 1.
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